Lung Ambition Alliance to award four new Junior Faculty Research Grants. Four early-career researchers have been selected to receive the Lung Ambition Alliance Junior Faculty Grants for the Study of COVID-19 and Lung Cancer. Research shows that patients with lung cancer have worse outcomes with COVID-19 and these grants are intended to fund groundbreaking research…

The IASLC has formed an alliance with the Global Lung Cancer Coalition (GLCC), Guardant Health, and AstraZeneca to accelerate the pace of lung cancer survival worldwide. This collaborative effort—known as the Lung Ambition Alliance—allows scientists, specialists, advocates, and patients to break the barriers limiting progress with a goal to double 5-year survival rates of lung…

The IASLC awarded four cancer care teams from around the globe with one of the association’s most prestigious award—the IASLC Cancer Care Team Award (CCTA). The winning teams were announced during the IASLC 2020 World Conference on Lung Cancer Singapore. The CCTA recognizes a single institution in North America, Europe, Latin America, and Asia/Rest of…

The latest in the series of diagnostic Atlases has been published by the IASLC and its Pathology Committee. Following the highly successful editions on ALK, EGFR, ROS1 and PD-L1, this latest Atlas takes a comprehensive look at diagnostic immunohistochemistry (IHC) and its role in thoracic pathology. The editorial team of Drs. Yasushi Yatabe, Alain Borczuk,…

Dr. Tetsuya Mitsudomi joined the Board of Directors of IASLC in 2011 and has served as its board president since 2019. IASLC awarded Dr. Mitsudomi its Mary J. Matthews Pathology/Translational Research Award in 2013 for a lifetime achievement in pathology and translational research of thoracic malignancies. Dr. Mitsudomi, professor in the Division of Thoracic Surgery…

Heather Wakelee, MD, is the President-Elect of the IASLC and will assume presidential responsibilities at the 2021 WCLC in September. She is the Chief of the Division of Oncology at Stanford University and Deputy Director of the Stanford Cancer Institute. She is also the principal investigator of numerous clinical trials and lead investigator for the…

With a long history in leadership positions at the IASLC, Dr. Scagliotti is fully prepared to help guide the society’s scientific projects through a transition period. Dr. Scagliotti, is professor of medical oncology at the University of Turin School of Medicine, Italy, where he is also a member of the administrative board. He is also…

Caroline Dive, CBE, PhD, FBPhS, FMedSci, Director of the CRUK Manchester Institute Cancer Biomarker Centre, University of Manchester, has been recognized by the IASLC with the Mary J. Matthews Pathology/Translational Research Award. The award recognizes an IASLC scientist for a lifetime achievement in pathology and translational research of thoracic malignancies. “I am utterly delighted and…

Pan-Chyr Yang, MD, PhD, Chair Professor at the National Taiwan University Hospital and Academician of Academia Sinica, Taiwan, will be recognized by the International Association for the Study of Lung Cancer (IASLC) with the Joseph W. Cullen Prevention/Early Detection Award at the fully virtual IASLC 2020 World Conference on Lung Cancer (WCLC). This award recognizes…